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INTRODUGTION 
The thymus is now recognized as the primary lym-
phoid organ involved in the differentiation of T Iym-
phocytes (1). In the human species, its physiolog-
ical role seems to be mainly exerted along fetal de-
velopment since congenital thymic hypo- or aplasia 
(Iike in the Di George's syndrome) is followed by a 
profound impairment of T cell functions, leading to 
the premature death of the child. On the contrary, 
ablation of the human thymus after birth is not fol-
lowed by significant immune deficiency. T cell on-
togeny is a highly complex process which can be 
divided in several distinct phases. Firstly, T cell pre-
cursors originating from the fetal liver and bone 
marrow migrate through separate waves into the 
thymic rudiment, most probably under the influence 
of specific chemoattractants (2). Secondly, within 
the thymus, immature T cells undergo rearrange-
me nt of the genes coding for the chains of their re-
ceptor for antigen (TcR), and express differentia-
tion markers (CDs) at their surface. These pro-
cesses are not purely automatic, but are intimately 
controlled by the thymic microenvironment (ep-
ithelial cells, macrophages, dendritic or interdigi-
tating cells, and fibrobiasts) (3). Thirdly and impor-
tantly, the thymus is the site for the negative selec-
tion of self reactive T cells and this mechanism is 
basically responsible for the induction of T cell self 
tolerance (self/non-self discrimination) (4-6).Finally, 
the integration by target pre-T cells of the various 
differentiative signals (adhesion molecules, growth 
factors, and cytokines (7)) encountered in the thy-
mus leads to the positive selection of mature im-
munocompetent T Iymphocytes (8). 
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GELL-GELL INTERAGTIONS IN THE THYMUS 
Thymic epithelial cells (TEC) constitute the major 
component of the environment controlling T cell dif-
ferentiation (9). They have a mixed, ectodermal and 
endodermal, origin (10, 11). The endoderm derives 
from the third pharyngeal pouch, while the ecto-
derm originates from the cervical and from the third 
branchial cleft. The majority of cortical TEC seem 
to derive from the endoderm, whereas the ecto-
derm would contribute to the subcapsular cortical 
epithelium, some stellate cortical cells, the 
medullary epithelium and the Hassall's corpuscles. 
Since Le Douarin's pioneering studies (12), it is weil 
acknowledged that the cephalic neural crest exerts 
an important influence upon thymic organogene-
sis, even if the exact contribution of neural crest mi-
grants in the thymus is still discussed. TEC of the 
subcapsular cortex and medulla also share com-
mon immunocytochemical characteristics, like their 
labelling with antisera directed against thymic pep-
tides (anti-thymosin a1 (13) and anti-thymulin (14)) 
or with monoclonal antibody (mAb) A2B5 (wh ich 
reacts with complex gangliosides found in the brain 
and the diffuse neuroendocrine system) (15). We 
have also demonstrated that the same subsets of 
TEC contain neurohypophysial (NHP)-related pep-
tides and immunoreactive (ir) interleukin-1 ß (IL-1 ß) 
(16, 17). Thymic nurse cells (TNC) are large ep-
ithelial cells which can be isolated by 1 9 sedimen-
tation from murine thymuses after enzymatic di-
gestion (18), and which have been identified in situ 
in the thymic subcapsular and outer cortex (19,20). 
TNC were also shown to synthetize NHP-related 
peptides, and to express the same immunopheno-
type as cellular elements belonging to the diffuse 
neuroendocrine system (21). 
Even if the thymus has been considered for many 
years to be an intrinsic component of the endocrine 
system, the pattern of secretion in TEC is rather dif-
ferent from the classical endocrine secretory pro-
cess (22). We have also demonstrated that the c1as-
sical scheme of neurosecretion established for the 
V. Geenen, F. Robert, H. Martens, et al. 
hypothalamo-NHP axis could not be applied to the 
thymic cell-to-cell signalling. The concept of cryp-
tocrine signalling (23) was recently introduced by 
J.w. Funder to describe the exchange of informa-
tions in secluded microenvironments created by 
large epithelial cells enclosing migratory develop-
ing cells. Two examples at least of cryptocrine sig-
nalling exist in the human body: one in the thymus, 
between TEC/fNC and immature T cells (pre-T cells 
or thymocytes); another in the testis, between Sertoli 
cells and spermatids. Interestingly, Sertoli cells have 
already been described in 1899 as "nurse" cells es-
sential for the germinal cell and the process of sper-
matogenesis (24). In the thymus, the mitotic index of 
TNC-engulfed thymocytes is rather high and recent 
studies have evidenced that TEC/fNC can present 
antigen+self major histocompatibility complex 
(MHC) (25). Consequently, it seems highly proba-
ble that TNC display the biochemical machinery to 
actively intervene in the selective process of T cells 
(26). The tolerogenic properties of TEC have also 
been illustrated in several experimental paradigms 
(27-29). On the basis of our observations, we have 
proposed that thymic NHP-related peptides could 
serve as functional signals in cryptocrine commu-
nication between TEC/fNC and pre-T cells (30). The 
analogy between TNC and testicular Sertoli cells is 
further supported by the recent observation of the 
expression of an oxytocin (OT) gene in cattle Sertoli 
cells (31), as weil as by the immuno-Iabelling of hu-
man Sertoli cells with mAbs A2B5 and 033 (direct-
ed against the cyclic part of OT (32)) (unpublished 
observations). If the molecular mechanisms under-
Iying the intrathymic expression of NHP-like pep-
tides remain to be further characterized, separate 
studies have confirmed the presence in the thymus 
of immunoreactive and bioactive OT-like peptide 
(33-35). Furthermore, the expression of functional 
NHP peptide receptors by rat thymocytes (36) and 
by murine immature and differentiated T cells is a 
prerequisite in favor of this working hypothesis (37). 
Since the intrathymic concentrations of NHP-relat-
ed signals are in good concordance with the high 
affinity Kd of NHP receptors expressed by pre-T 
cells, the physico-biochemical conditions are en-
countered to render effective in vive a thymic cryp-
tocrine signalling through NHP peptides and their 
cognate receptors. This is obviously not the case 
for circulating neurohormones OT and VP, due to 
their low blood concentrations. The pre-T cell NHP 
receptors were shown to mediate mitogenic prop-
erties of NHP-related signals upon human and 
murine pre-T cells. Their transductory properties in-
volve a T cell phosphoinositide breakdown and 
were similar to those described for other V1/0T re-
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ceptors. This effect was specifically inhibited by a 
V1 antagonist in pre-T cells and by an OT antagonist 
in cytotoxic T cells (37). This shift in the type of T 
cell NHP receptor may suggest a dynamic phe-
nomenon of molecular maturation parallel to the 
progress of T cells in their differentiative pro-
gramme. As evidenced by our previous radiobind-
ing studies (38), the V1 receptor expressed by pre-
T cells is probably an immune-specific V1 subtype 
different from the recently cloned V1 a receptor (39). 
In the murine species, other authors have also re-
ported the expression of a novel V1 subtype by 
splenic cytotoxic Iymphocytes (40). Of course, the 
TNC-derived NHP signals are not the only growth 
factors implicated in T cell differentiation, but their 
mitogenic properties evidenced on pre-T cells may 
provide an explanation to the high mitotic index of 
TNC-engulfed thymocytes. They also demonstrate 
an implication of thymic NHP-related peptides in the 
process of T cell positive selection, in accordance 
with previous observations (41). Molecular distur-
bances of cryptocrine signalling might also inter-
vene in pathologic states, either at the level of NHP 
signal (thymoma are the third cause of inappropriate 
VP secretion (42, 43)), or at the level of NHP recep-
tor (with potential implication in T cell lymphoma 
oncogenesis). Interestingly, the intervention of TNC 
in leukemogenic process have al ready been 
demonstrated before (44). The expression of NHP 
peptide receptors by immune cells also opens nov-
el immunomodulatory strategies through the molec-
ular design of neuropeptide immune-specific re-
ceptor antagonists or agonists. We recently de-
scribed a significant inhibition by novel OT non-
peptide antagonists (Merck Sharp & Dohme 
Research Laboratories, West Point) of IL-1 ß, IL-6 
and TNFa productions in human whole blood cell 
cultures stimulated by anti-CD3 mAb (45). This in-
hibition was significantly more important in whole 
blood cell cultures derived from human female vol-
unteers, suggesting an influence of the gonadal 
steroid hormonal environment. The future knowl-
edge of the precise NHP receptor subtypes ex-
pressed by immunocompetent cell populations 
should help computer modelling and molecular en-
gineering of speciflc immunomodulatory com-
pounds based on the basal structure of these OT 
cyclic hexapeptide antagonists. This approach 
could lead to selective immunotherapy in cruciallife 
periods, such as the postpartum, during which an 
immune disequilibrium is determined byan increase 
of the oestrogen/progesterone ratio and by a rise in 
immunostimulatory lactogenic hormones prolactin 
and OT. 
Within cryptocrine microenvironments, the sense of 
chemical information mayaiso be directed from the 
engulfed developing cells to the large epithelial 
"nursing" cell. This seems to be the case with nerve 
growth factor (NGF) since this was shown to be 
synthesized by male germ cells (46), whereas NGF 
receptor was shown to be expressed by Sertoli 
cells (47). An analogous situation may exist within 
thymic microenvironment as NGF receptor mRNA 
was also detected in chick and rat thymus extracts 
(48), but the precise source of the thymic NGF sig-
nal remains to be further defined. Of high relevant 
interest with regard to the role of NGF in thymic 
physiology is the recent observation that this neu-
rotrophic factor markedly enhances the molecular 
and phenotypic neuronal-like features of cultured 
murineTEC (49). 
T GELL REGOGNlTlON OF SELF 
NEUROENDOGRINE FUNGTIONS 
Neurohypophysial (NHP) peptide family 
Through the use of several well-characterized poly-
clonal and mAbs, we have defined the immu-
nodominant epitopes representative of the NHP 
peptide family expressed by TEC{TNC of several 
animal species (50). The first epitope is located, at 
least partially, in the six amino acid cyclic part 
shared by OT and by vasotocin (VT), the ancestral 
peptide precursor of the NHP family constituted by 
the cyclic part of OT and the three amino acid lat-
eral chain of VP. The second epitope is present in 
the central "constant" part of the neurophysin do-
main. This part is encoded by the second exon of 
NHP genes and show a high degree of conserva-
tion (> 90%) throughout the evolution of species 
whichever the nonapeptide associated (51). In the 
overall evolution of intercellular communication, the 
cryptocrine stage evidenced in the thymus intro-
duced an obligatory step which is the recognition of 
the self molecular structure by developing T cells. 
This would logically follow the presentation by 
thymic MHC molecules of self epitopes represen-
tative of larger proteins. The size of the MHC groove 
allows the binding of peptide sequences ranging 
from a minimum of five (52) to seventeen amino 
acids in length (53). If demonstrated, the presen-
tation by thymic MHC molecules of the NHP self 
epitopes could therefore induce the central immune 
tolerance of hypothalamo-NHP functions. This 
tolerogenic effect would result from the clonal dele-
tion of highly reactive T cells harboring a random-
Iy rearranged TcR specific for the association 
MHC/self NHP epitope(s). The large involvement of 
OT-like peptides at different levels of the repro-
ductive processes implies that they are strongly tol-
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erated by the immune system. This high tolerance 
of OT lineage protects it from a potential autoim-
mune aggression and would therefore contribute 
to the preservation of the species. Since VP differs 
from NHP self epitope by one single amino acid in 
its cyclic part, it is less "protected" from autoim-
mune process. Indeed, some authors have previ-
ously reported "idiopathic" diabetes insipidus re-
sulting from autoimmune aggression directed 
against hypothalamic magnocellular neurones (54). 
In the same view, experimental breakdown of NHP 
immune tolerance by active immunization against 
VP was also shown to induce inflammatory lesions 
in the hypothalamo-NHP axis (55). It is also inter-
esting to note that the frequence and the titers of 
antisera against VP are usually higher than those 
of anti sera developed against OT or VT. 
So, the deep investigation of our original observa-
tions (56) led us to shift from the classical neu-
rosecretion model to the novel pathways underlying 
cryptocrine cell-to-cell signalling and self antigen 
presentation by MHC molecules. At the molecular 
level, the "neuropeptide" model was replaced by 
the working concept of NHP "self peptide" (57, 58). 
As discussed before, thymic NHP-related self pep-
tides exert a dual role in T cell differentiation ac-
cording to the type of intercellular dialogue in wh ich 
they are engaged (cryptocrine signalling or NHP 
self antigen presentation by thymic MHC). 
Tachykinin (TK) peptide family 
This model of a dual physiological role for thymic 
self peptides also applies to this family whose in-
trathymic expression was investigated in collabo-
ration with the Laboratory of Molecular 
Neurobiology at the Karolinska Institute 
(Stockholm). Neurokinin A (NKA) is the TK peptide 
encoded by preprotachykinin-A (PPT-A) gene in 
the rat thymus (59) and is thus the first member of 
the TK family encountered by developing T cells. 
Mitogenic activities have been described for NKA 
and physalaemin upon murine cultured thymocytes 
(IL-1-like bioactivity), while substance P (SP) and 
other TK-related peptides did not exert any signif-
icant effect (60). These observations strongly sup-
port the involvement of thymic NKA in T cell positive 
selection. Since NKA shares with other TKs the 
same C-terminal immunodominant epitope, it might 
represent the tolerogenic TK peptide that is ex-
pressed in the thymus and is facing the develop-
ing T cell system. The other TK peptide SP detect-
ed in rat and human thymic extracts is associated 
with sensory nerve fibers and seems to be impli-
cated in the regulation of thymic blood flow (61, 62). 
This does not exclude that SP exerts peripheral 
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proinflammatory properties, however through spe-
cific immune TK receptors since potential TK au-
toreactive T cells would have been deleted in the 
thymus. 
Insulin peptide family 
Insulin-like growth factors (IGFs) were also identi-
fied within the human fetal thymus, both at the pep-
tide and mRNA levels (63,64). 
However, these studies could not really discrimi-
nate between IGF-I or IGF-II, and the thymic sub-
cellular localization remains to be further defined 
because of the discrepancies observed between 
the localizations of IGF mRNAs and immunoreac-
tivities. The fact that thymic IGFs are implicated as 
accessory signals in T cell positive selection is in-
directly suggested by the mitogenic properties of 
IGF-I on pre-T thymic lymphoma cells (65). The ac-
tivation of human T Iymphocytes by anti-CD3 also 
leads to their expression of IGF-I and IGF-II recep-
tors (66). Due to the high homology (± 60%) of 
proinsulin and IGFs primary amino acid sequences, 
the tolerance of pancreatic endocrine function 
could result from the intrathymic deletion of T cells 
harboring a rearranged TcR specific of the associ-
ation thymic MHC/insulin family self epitopes. The 
IGF-II region on chromosome 11 p seems also to 
be involved in HLA-DR4-dependent diabetes sus-
ceptibility by a still undefined molecular mechanism 
(67). So, further characterization of the precise in-
sulin/IGF-derived self immunodominant epitope ex-
pressed in the human thymus should lead to the 
identification of the primary self antigen implicated 
in the autoimmune cascade leading to overt insulin-
dependent diabetes. In another connection, sev-
eral antigenic markers are shared between 
TEC/TNC, and pancreatic islet ß-cells, among 
which A2B5 and HISL (68). This cellular phenotyp-
ical relationships may suggest a common embry-
onic origin in the neurectoderm or in the neural 
crest (69). 
Other members of the thymic peptide repertoire 
Several neuroendocrine peptides have been de-
tected in the thymus from various species, at the 
peptide or the mRNA level (70-75). In two of these 
studies, neuropeptides were ultrastructurally de-
tected in perinuclear space, vesicular structures 
and rough endoplasmic reticulum, but not in clas-
sical secretory granules. Since an atrial natriuretic 
peptide (ANP) signal is found in thymic stroma and 
that ANP receptors are also expressed by rat thy-
mocytes, a functional accessory signalling through 
this peptide should also be further investigated in 
the process of T cell development (76). An au-
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tocrine/paracrine signalling through luteinizing hor-
mone-releasing factor (LHRH) seems also to inter-
vene in the modulation of the T cell differentiation 
pathways (77, 78). Parathormone-related peptide 
(PTH-RP), as weil as calcitonin gene-related pep-
tide (CGRP) were also recently found to be includ-
ed in the thymic self peptide repertoire (79, 80). 
Both of these polypeptides shared common amino 
acid sequences with the hormonal members (PTH 
and CT) of their corresponding family and could 
therefore induce T cell tolerance of PTH- and CT-
mediated endocrine functions. 
NEURAL AND ENDOCRINE CONTROLS OF 
THYMIC FUNCTION 
Like all peripheral organs, the thymus receives au-
tonomic sympathetic and parasympathetic inner-
vation (81, 82). A number of neuropeptides have 
also been identified in sensory nerve fibers of the 
thymus (83). At the present time, it is however still 
difficult to establish whether these innervations ex-
ert a control upon thymic stromal cells, thymic 
blood flow or may directly act upon differentiating T 
cells. 
The thymic physiological role is also closely influ-
enced by the endocrine environment, in particular 
by thyroid (84) and antehypophysial hormones (85), 
as weil as by gonadal steroids and glucocorticoids 
(86, 88). There is increasing evidence that these 
hormonal influences may be relayed by intrathymic 
factors (i.e. the trophic role of growth hormone up-
on the thymus (89) is most probably mediated by 
local actions of thymic IGF-I). To our knowledge, 
the existence of a specific antehypophysial thy-
motrophin has never been investigated but this 
question deserves further attention given the inti-
mate relationships between the thymus and the pi-
tuitary (90). 
CONCLUSIONS 
The ontogenetical and phylogenetical evolutions of 
the endocrine system have seen the emergence of 
various forms of intercellular communication, from 
the most primitive stages of autocrine signalling 
(when a cell is alone) and adhesion (wh ich follows 
the division of one cell) to the most complex neu-
rocrine networks underlying cognitive processes in 
the central nervous system. Parallel to the succes-
sive structural levels of the evolution of intercellu-
lar communication, it appeared some hierarchy in 
the genomic organisation responsible for the trans-
fer of biochemical information between cell popu-
lations (91). In recent years, new members of en-
docrine families were identified through the use of 
molecular techniques. These factors were not clas-
sical "hormones" vehiculated by bloodstream, but 
rather exerted local growth-promoting "paracrine-
autocrine" activities. It also appeared that these tis-
sue peptide growth factors were predominantly ex-
pressed during fetal life and were playing an im-
portant role in embryo development and organo-
genesis. Their etiopathogenic involvement in neo-
plasic processes is more and more documented, 
and their gene overexpression is sometimes fol-
lowed by a massive release in bloodflow. A para-
neoplasic syndrome may then follow, due to the 
usual cross-reactivity of these tissue growth-factors 
with the relative hormone receptors. On the other 
side, the immune system has evolved, the primary 
characteristic of which is the protection of the self 
molecular structure against foreign infectious in-
vaders (non-self). The thymus is one crucial privi-
leged site for which appears as an obligatory step 
in the parallel evolutions of neuroendocrine and im-
mune systems: the education of T cells to discrim-
inate self antigens and foreign (non-self) antigens. 
In the line of that highly simplified perspective, the 
incidental breakdown of self immune tolerance as 
seen in autoimmune pathologies may be consid-
ered as the global tribute paid by one given 
species for its protection against infectious non-self 
antigens. 
In the actual stage of our research on the neuroen-
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Fig. 1 - Thymic education of T cells in self neuroendocrine prin-
ciples.· model of the dual physiological role of thymic self pep-
tides in T cell differentiation. 
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mus, this primary lymphoid organ appears more and 
more as a highly specialized school for the education 
of T cells in self neuroendocrine principles (Fig. 1). In 
the human species,that school is mainly working 
du ring fetal development and its highest education-
al degree is the apoptosis of the autoreactive T cells 
(92). A failure in the educational programme would 
result in the emergence of T cells with autoreactivity 
directed against neuroendocrine self antigen(s), and 
this point could play an important pathogenetic role 
in endocrine autoimmune diseases. Of course, the 
appearance of autoreactive T cells is not the only 
etiopathogenic factor in autoimmunity (93) and the 
thymic T cell negative selection is not a perfect 
mechanism (94). Nevertheless, it is the only one for 
which the precise description of the underlying 
molecular mechanisms should allow novel diagnos-
tic and preventive therapeutic intervention. Another 
important conclusion which can be drawn from our 
work is the fact that the thymus is not the site for the 
expression of all neuropeptide genes, but apparently 
only of the genes coding for representative mem-
bers of neuroendocrine families. Although funda-
mental, the central immune tolerance of neuroen-
docrine functions does not of course exclude the 
possibility of other peripheral tolerogenic mecha-
nisms, as recently demonstrated by the inhibition of 
the diabetogenic process in NOD mice fed with het-
erologous insulin (95). This observation is another 
indication that the whole peripheral T cell repertoire 
is not shaped by self antigens alone, but that envi-
ronmental factors mayaiso contribute to this funda-
mental process. This latter point has already been 
shown for non-inherited maternal HLA antigens (96). 
As already shown, new immunomodulating strate-
gies may be designed on the pharmacological ma-
nipulation of the cryptocrine signalling (45). 
Innovative testing procedures for the detection of 
high-risk patients and preventive therapeutics of en-
docrine autoimmune disorders mayaiso be con-
structed on our model of the thymic repertoire of neu-
roendocrine self antigens. 
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